BIN SABBAR, N. S.; ALOWIRDI, F. S.; BASAKRAN, F. A.; AL-BADR, L. A.; ASSIRI, R. A.; ALSHAHRANI, W. A.; ALTHUBAITI, A.; DAMLAJ, M. Addition of rituximab to hyper-CVAD improves overall survival in newly diagnosed Burkitt leukemia/lymphoma from the Middle East and North Africa region. International Journal Of Community Medicine And Public Health, [S. l.], v. 6, n. 10, p. 4199–4203, 2019. DOI: 10.18203/2394-6040.ijcmph20194475. Disponível em: https://www.ijcmph.com/index.php/ijcmph/article/view/5294. Acesso em: 30 mar. 2026.